Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on July 25, 2025
Naval Postgraduate School Scholar on the Forefront of Golden Dome Technology
EIN Presswire
·
July 25, 2025
Leveraging a space-based terahertz camera aboard a Naval Postgraduate School (NPS) CubeSat, a recent graduate's research could shape future missile defense. MONTEREY , CA, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- U.S. Navy Lt. Christopher …
Congressional resolution seeks to protect and advance biomedical research
EIN Presswire
·
July 25, 2025
Congressional resolution reaffirms the federal government's role in funding and advancing American biomedical research. WASHINGTON, DC, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- On July 24th, Reps. Diana DeGette (D-CO), Jamie Raskin (D-MD), …
The Brookbush Institute Publishes a NEW Article: 'Judging a Personal Trainer by Appearance'
EIN Presswire
·
July 25, 2025
Personal Trainers and Coaches Should Not Be Judged on Their Looks or Lifts. (And Why Equating Muscles with Knowledge is a Sign of Ignorance) NEW YORK, NY, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- Excerpt From the Article: Judging a Personal …
BioCellgraft advances strategic commercialization planning for OraFyl™ with its partner Celularity, Inc.
EIN Presswire
·
July 25, 2025
BioCellgraft's recent successful collection of patient cases using OraFyl in dozens of gum and bone related dental procedures positions the product to dominate. NEW YORK, NY, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- OraFyl™, BioCellgraft’s …
UNEP FI Features ESGSignals® in Its Newest Sustainability Risk Dashboard
EIN Presswire
·
July 25, 2025
The database is comprised of leading suppliers of sustainability insights for the climate and physical risk assessment needs of capital markets NEW YORK, NY, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- RS Metrics is among the risk data providers …
High-efficacy adjuvanted subunit vaccine against variant infectious bursal disease virus in chicks
EIN Presswire
·
July 25, 2025
FAYETTEVILLE, GA, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- A recent study demonstrates that the IBDV VP2 subunit vaccine prepared in this study was able to induce the production of specific antibodies, inhibit bursal atrophy and resist viral …
MOPE Clinic Highlights the Vital Role of DHEA in Hormonal Health for Men and Women
EIN Presswire
·
July 25, 2025
New research and clinical insights support the use of DHEA supplementation in optimizing hormones, improving vitality, and supporting overall wellness in adults NEW ORLEANS, LA, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- MOPE Clinic, a leading …
Wickfield Capital engages Loop Capital Markets as exclusive investment bank for upcoming Signpath Pharma Capital Raise
EIN Presswire
·
July 25, 2025
Signpath Pharma, a portfolio company of Wickfield Capital, engaged Loop Capital Markets to raise capital for Signpath’s pivotal Phase III clinical trials. SANDY, UT, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- Signpath Pharma, a portfolio company …
BlackRock® Canada Announces Final July Cash Distributions for the iShares® Premium Money Market ETF
GlobeNewswire
·
July 25, 2025
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final July 2025 cash distributions for iShares Premium Money …
Kinross announces sale of shares of White Gold
GlobeNewswire
·
July 25, 2025
(All dollar amounts are expressed in Canadian dollars, unless otherwise noted.) TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (“Kinross” or the “Company”) (TSX: K, NYSE: KGC) announced today that it has sold an aggregate of 23,681,160 …
PharmAla Issues Q3 Financial Statements
GlobeNewswire
·
July 25, 2025
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA ( …
Targeting nufip1: a new strategy for sepsis treatment through ribophagy
EIN Presswire
·
July 25, 2025
GA, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- Sepsis-induced immune dysfunction is a major contributor to high mortality rates in septic patients. Recent findings shed light on the role of nuclear fragile X mental retardation-interacting protein …
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025
GlobeNewswire
·
July 25, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
Leap Local Launches Map Pack SEO Service to Help Small Businesses Rank Higher on Google Maps
GlobeNewswire
·
July 25, 2025
Greensboro, NC, July 25, 2025 (GLOBE NEWSWIRE) -- Leap Local, a digital marketing company dedicated to supporting local businesses, has launched its new Map Pack SEO service. The service is designed to improve visibility in Google’s Local 3-Pack, helping …
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025
GlobeNewswire
·
July 25, 2025
DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands, with a portfolio of novel multi-targeted …
Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer
GlobeNewswire
·
July 25, 2025
MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the Company will hold a conference call and webcast on Monday, July …
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
GlobeNewswire
·
July 25, 2025
Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active treatment arms compared to placebo, but did not meet statistical significance on the primary endpoint Inidascamine continues to …
NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups
GlobeNewswire
·
July 25, 2025
TORONTO and HAIFA, Israel, July 25, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that the Falling Walls Foundation has named the Company a finalist in Falling …
Treatment.com AI Announces Non-Brokered Private Placement of up to C$3 million of Special Warrants and Units
GlobeNewswire
·
July 25, 2025
Vancouver, British Columbia, July 25, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; 939: FRA) is pleased to announce that due to strong inbound interest from new and existing investors, it is …
POP BIO and CEPI announce collaboration for faster responses to Disease X
GlobeNewswire
·
July 25, 2025
Buffalo, NY, July 25, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a biotechnology company specializing in nanoparticle-based vaccines, and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a new collaboration to …